Islam & Harm Reduction Adeeba Kamarulzaman

Slides:



Advertisements
Similar presentations
The need to challenge unhealthy drug policies to improve drug treatment Dr Chris Ford, Holly Catania and Rebecca Murchie IDHDP.
Advertisements

HIV and Harm Reduction Winning on policy front : Faltering on Implementation JVR Prasada Rao, UNAIDS XVIII International Harm Reduction Conference Warsaw,
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
THE ILO and HIV/AIDS A DIA Insa Ben Said Turin 02/09/2005.
H. Naning1, C. Kerr2, A. Kamarulzaman1, M. Dahlui3, CW Ng3, D. Wilson2
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
Combined prevention programs within criminal justice systems – examples from Malaysia A Kamarulzaman, S Kaur, MN Nazar, M Azahari, C Koh, H AlDarraji,
Rolling Out The National Harm Reduction Programme in Malaysia
Supporting community action on AIDS in developing countries MDG’s and the Law: Creating an Enabling Legislative Environment Anton Kerr Head of Policy –
Aimed at Key Affected Population Groups.  Clinical social franchising is a model for organizing networks of private providers  to deliver a range of.
VISION ZERO NEW HIV INFECTIONS. ZERO DISCRIMINATION. ZERO AIDS-RELATED DEATHS.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
HIV frameworks & policies: Where do migrants and mobile populations fit? Adeeba Kamarulzaman University of Malaya Kuala Lumpur, Malaysia HIV PREVENTION.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
CALL TO ACTION for Overcoming HIV in Conservative Social Settings Dr. Adeeba Kamarulzaman, University of Malaya, Malaysia Satellite Session: Overcoming.
Asia-Pacific High-level Meeting on HIV and AIDS The Asia-Pacific High-level Intergovernmental Meeting on the Assessment of Progress against Commitments.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Essential package of targeted interventions for MARA Romania Experience.
There is no single epidemic in the Middle East and North Africa – learning from facts to shape the AIDS response UNAIDS Secretariat, the World Bank and.
Current Substance Abuse Disorders and HIV Situation in Malaysia B. Vicknasingam (1), Singh, D (1), Suppiah, B (1), Schottenfeld, R (2) and Chawarski, M.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Malaysia Last updated: July 2015.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
Project RAS/H13 “Prevention of transmission of HIV among drug users in SAARC Countries” Lubna Mohamed Zahir Hussain Chairperson of National Drug Agency.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Regional Videoconference Addressing Stigma and Discrimination of HIV/AIDS in Africa Thursday, April 2, 2009 UNAIDS Perspective Susan Timberlake, Senior.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Viet Nam Last updated: July 2015.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: June 2015.
HIV and AIDS Data Hub for Asia-Pacific Review in slides China Last Updated: August 2015.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: April 2016.
Enabling Policy Environments for more Effective HIV Responses among Gay and Bisexual and other Men who have Sex with Men Vitaliy Karanda, Program Support.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
2008 International AIDS Conference UNGASS reporting Matthew Warner-Smith Monitoring and Evaluation Division UNAIDS 2008 International AIDS Conference Satellite.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
HIV Epidemic in Malaysia. HIV BY AGE GROUPS - MALAYSIA.
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Cascade of care for people who use drugs - opportunities for integration and scale up of harm reduction services and other evidence based interventions.
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Bhutan Last updated: September 2016.
Opportunities and prospects.
China Last Updated: April 2016.
Needle and syringe exchange and working with injecting drug users
Review in slides Malaysia.
Pakistan Last updated: July 2015.
Malaysia: Needle Syringe and Exchange Program (NSEP)
Drugs and HIV in Southeast Asia
Myanmar Last Update: September 2016.
Addressing Vulnerability of Women IDUs in Manipur
Key Affected Populations
Reaching out to hidden population in Malaysia
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Edward Mbizo Sibanda, (MSc) Right to Care
China 2010 UNGASS Country Progress Report
The HIV Epidemic among People who Inject Drugs
Biomedical Prevention Is Always About Social Justice, Too
Myanmar Last Update: November 2014.
Key Affected Populations
Data Hub for Asia-Pacific Review in slides Philippines
Malaysia Last updated: August 2018.
Bhutan Last updated: July 2018.
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 30 March 2011 Slide 1 A brief introduction.
Presentation transcript:

Islam & Harm Reduction Adeeba Kamarulzaman Faculty of Medicine, University of Malaya Member, IAS Governing Council

Intervention Outcome Summary of studies Evidence Statement Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness Intervention Outcome Summary of studies Evidence Statement Needle and syringe programmes (NSP) Injecting risk behaviour (IRB) 43 studies Sufficient evidence to support the effectiveness HIV 16 studies Tentative evidence to support the Opiate Substitution Treatment (OST) IRB 35 studies 8 studies McArthur G et al. IJDP Jan 2014

“Mega-Epidemics” Wolfe D. Lancet August 2010

The higher purposes of Islamic law Maqqasid Syariah Preservation of Faith Life Intellect Progeny Wealth

Legal maxims in Islam “A lesser harm may be tolerated in order to eliminate a greater harm” “A particular harm may be tolerated in order to prevent a general one” “Public interest (Maslahah ammah) must be given priority over private concerns” “Harm must be treated and benefits must be brought forth”

Jan 2004 Formation of Harm Reduction Working Group June 2005 MOH approves harm reduction programs June 2005 Formation of National Harm Reduction Task Force Oct 2005 Pilot MMT program implemented Feb 2006 Pilot NSP program implemented April 2006 Cabinet Endorsement for Harm Reduction Program

National Task Force on Harm Reduction Ministry of Health Ministry of Internal Security Police National Antidrugs Agency Prisons Department Malaysian AIDS Council JAKIM Academia

MALAYSIAN HARM REDUCTION PROGRAM 2005-2015 NSP 2006 – 2010 Reduce HIV vulnerability among IDU NSP 2011 – 2015 prevent / reduce infection, improve QoL of PLHIV, and reduce the social and economic impact Up scaling of harm reduction program 2001 - 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Jan 29,05 : PM statement on MDG HIV Jan 15 – endorsement of MMT by MTMDK June 3, 05 : MoH annoucement on NSEP June 23,05 : NTFHR Oct, 05 : MMT piloted Review of SOP 2nd Review of SOP Piloted Klinik Kesihatan Angkat Project 3rd Review of SOP NSPEA consultation MMT in prison and NADA NSEP at health clinic Endorsement of up scaling of harm reduction in NSP 2011-2015 Endorsement of up scaling MMT by JRP meeting Harm Reduction program by Global Fund Support activities of harm reduction by HIV/AIDS Alliance funding NSPEA preparatory work Feb 2006 : NSEP piloted April 2006 – Malaysia cabinet Endorsement on HR 2001 - The Declaration of Commitment on HIV/AIDS adopted by United Nation General Assembly Special Session on HIV/AIDS (UNGASS) in 2001, for which Malaysia was a signatory 2002- 2005 : Proposal of harm reduction

NUMBER OF REGISTERED PATIENTS ON OST AND OST CENTERS 2006 – 2014 YEAR 2006 2007 2008 2009 2010 2011 2012 2013 2014 No. of registered patients at Govt Facilities (Cumulative) 1,241 4,018 7,065 10,730 15,869 20,955 27,756 33,444 37,555 No. of registered patient at Private Facilities (Cumulative) NA 12,566 17,976 21,203 23,010 23,257 24,324 31,805 37,261 Total No. of registered patient (Cumulative) 16,584 25,041 31,933 38,879 44,212 52,080 65,249 74,816 Public OST Facilities 17 66 75 162 240 292 333 446 472 Private OST Facilities 306 300 382 365 366 Total OST centers (Govt + GP Setting) 372 381 462 540 674 715 811 838 Source : Disease Control Division, MoH Malaysia

NSP PROGRAM 2006 – 2014   Year 2006 2007 2008 2009 2010 2011 2012 2013 2014 NSP Site : NGO 45 70 114 218 224 221 529 576 540 NSP Site : Health Clinic 6 22 73 76 152 TOTAL 120 240 297 605 728 692 Registered Clients (cumulative) 4,357 6,658 12,230 18,377 24,999 34,244 55,298 72,686 85,693 Needle & Syringe return rate 58.6% 62.2% 63.2% 65.9% 56.4% 63% 58.9% 61.5% 60.0% Source : Ministry of Health, Malaysia

Malaysia Annual Reported HIV Cases 2000-2014 AIDS/STI Section, Ministry of Health Malaysia. 2015

Transformation of Compulsory Drug Detention Centers into Voluntary Treatment & Care Centers

Major Developments since 2010 COMPULSORY REHABILITATION OPEN ACCESS AMBULATORY VOLUNTARY CENTRES 19 CURE & CARE REHABILITATION CENTRES 11 CURE & CARE 1MALAYSIA CLINICS Sangeeth Kaur IAS 2013

C&C – Outcome Study 28663 had received services at C&C or CCSC between 2010 and April 2013 Of 313 interviewed 56.3% - Helped maintain employment 54.3% - Continued education 77.6% - Improved family relations 72.1% - Obtained permanent homes 75.9% - Prevented arrest into prisons

New HIV Infections With Harm Reduction Without Harm Reduction Prevented New HIV Infections 2006-2013 20,903 34,220 39% 2013-2023 3,596 27,118 87% 2006-2050 27,979 134,345 79%

Cost Savings in Direct Health Care By preventing HIV transmissions among PWIDs, the harm reduction programmes allowed the government to accrue savings from direct health care costs Cost-saving in direct health care (mil. RM) 2006 - 2013 2013 - 2023 2006 - 2050 47.06 (30.53 – 58.50) 209.53 (114.10 – 248.26) 909.47 (441.71 – 1182.40) Direct health care cost savings from avoided infection are expected to increase over time due to disease progression for those who are not on treatment require higher intensity health care and higher health care cost for government

People Who Inject Drugs & the Heroin Trade There are 625,000 PWID in MENA Mumtaz G, et al. HIV among people who inject drugs in the Middle East and North Africa: Systematic review and data synthesis. PLoS Medicine, in press.

Emerging HIV Epidemics among People Who Inject Drugs At least one-third of MENA countries are affected by emerging HIV epidemics among PWID Only in the last few years Pakistan one of the worst globally; Libya has the highest prev rate among IDUs Mumtaz G, et al. HIV among people who inject drugs in the Middle East and North Africa: Systematic review and data synthesis. PLoS Medicine, in press.

Cairo Declaration of Human Rights "All men are equal in terms of basic human dignity and basic obligations and responsibilities, without any discrimination on the basis of race, colour, language, belief, sex, religion, political affiliation, social status or other considerations. True religion is the guarantee for enhancing such dignity along the path to human integrity."